Sera Prognostics, Inc. SERA
1.99 USD -0.20 (-9.13%)
At closeNov 10, 2026, 4:00 PM EST
2.02 +0.03 +1.51%
After hours · Nov 10, 4:00 PM ET
1.97 Day range 2.18
1.56 52-week range 3.85
- YTD
- -32.54%
- 1 year
- -21.96%
News
seekingalpha.com Sera Prognostics, Inc. (SERA) Q3 2026 Earnings Call Transcript Sera Prognostics, Inc. ( SERA ) Q3 2026 Earnings Call November 4, 2026 5:00 PM EST Company Participants Jennifer Zibuda - Head of Investor Relations Evguenia Lindgardt - President, CEO & Director Lee…
marketbeat.com What Sera Prognostics (SERA) Said on Its Q3 Earnings Call Sera Prognostics NASDAQ: SERA reported a sharp increase in use of its PreTRM preterm birth risk test in the third quarter of 2026, as the company expanded its commercial efforts in Illinois and…
zacks.com Sera Prognostics, Inc. (SERA) Reports Q3 Loss, Lags Revenue Estimates Sera Prognostics, Inc. (SERA) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.16 per share a year ago.
benzinga.com Sera Prognostics Q3 2026 Earnings Call Transcript Sera Prognostics (NASDAQ:SERA) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…
benzinga.com Sera Prognostics Q3 EPS $(0.16) Misses $(0.14) Estimate, Sales $42.000K Miss $72.500K Estimate Sera Prognostics (NASDAQ:SERA) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.14) by 14.29 percent. This is unchanged from the same period last…
prnewswire.com SERA PROGNOSTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS Company Drives Significant Increases in Test Volume and Ordering Providers with Florida Becoming Second Medicaid State Covering Test PreTRM® test volume increases 54% sequentially and approximately…
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Disc Medicine (NASDAQ:IRON) stock moved upwards by 50.4% to $85.51 during Monday's pre-market session. The company's market cap stands at $2.1 billion. DataMEDS AI (NASDAQ:MEDS) shares moved…